Michael P Heffernan, Milan J Anadkat. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansInfliximabInfusions, IntravenousMiddle AgedSarcoidosis/diagnosisSarcoidosis/drug therapySeverity of Illness IndexSkin Diseases/diagnosisSkin Diseases/drug therapyTreatment Outcome
Substances: See more » Antibodies, MonoclonalInfliximab
Year: 2005 PMID: 16027318 DOI: 10.1001/archderm.141.7.910
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X